Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers. This is the main finding of the latest research by Dr. Marcus Buschbeck and Dr.

MUD HCT is associated with better survival outcomes and fewer severe complications compared to haploidentical HCT in acute ...

Almost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation ...

Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the 67th American Society of Hematology (ASH) ...

Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...